|
Research & Development (Quarter)
|
| | | -0.04M | | -0.03M | | -0.04M | 203.11M | 209.01M |
|
Operating Expenses (Quarter)
|
| | | -0.04M | | -0.03M | | -0.04M | 203.11M | 209.01M |
|
EBIT (Quarter)
|
| | | -5.86M | | -2.75M | | -4.72M | | |
|
EBT (Quarter)
|
| | | -5.81M | | -2.75M | | -4.72M | | |
|
Profit After Tax (Quarter)
|
| | | -5.81M | | -2.75M | | -4.72M | | |
|
Investment Income (Quarter)
|
| | | | | | | -0.88M | | |
|
Income from Continuing Operations (Quarter)
|
| | | -5.81M | | -2.75M | | -4.72M | | |
|
Consolidated Net Income (Quarter)
|
| | | -5.81M | | -2.75M | | -4.72M | | |
|
Income towards Parent Company (Quarter)
|
| | | -5.81M | | -2.75M | | -4.72M | | |
|
Net Income towards Common Stockholders (Quarter)
|
| | | -5.81M | | -2.75M | | -4.72M | | |
|
EPS (Basic) (Quarter)
|
| | | -0.02M | | -0.02M | | -0.02 | | |
|
EPS (Weighted Average and Diluted) (Quarter)
|
| | | -0.02M | | -0.02M | | -0.02M | | |
|
Shares Outstanding (Weighted Average) (Quarter)
|
1,101.24M | 1,460.55M | 1,497.93M | 270.00 | 2,098.82M | 130.00 | 2,325.61M | 286.86M | 2,608.17M | 309.50M |
|
Shares Outstanding (Diluted Average) (Quarter)
|
| | | 270.00 | | 130.00 | | 200.00 | | 170.00 |
|
EBITDA (Quarter)
|
| | | -5.86M | | -2.75M | | -4.72M | | |
|
Interest Expenses (Quarter)
|
| | | -0.05M | | -0.01M | | -0.01M | | |